VELCADE®,Rituximab,Cyclophosphamide and Decadron (VRCD Regimen)
This study has been completed.
Sponsor:
Oncology Specialists, S.C.
Collaborator:
Millennium Pharmaceuticals, Inc.
Information provided by (Responsible Party):
Dr. Chadi Nabhan, Oncology Specialists, S.C.
ClinicalTrials.gov Identifier:
NCT00413959
First received: December 19, 2006
Last updated: December 7, 2012
Last verified: December 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | January 2011 |
| Primary Completion Date: | January 2011 (Final data collection date for primary outcome measure) |